miglustat has been researched along with colforsin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becq, F; Billet, A; Callebaut, I; Jollivet, M; Melin, P; Mornon, JP | 1 |
| Becq, F; Boinot, C; Ferru-Clément, R; Jollivet Souchet, M | 1 |
2 other study(ies) available for miglustat and colforsin
| Article | Year |
|---|---|
C terminus of nucleotide binding domain 1 contains critical features for cystic fibrosis transmembrane conductance regulator trafficking and activation.
Topics: 1-Deoxynojirimycin; Blotting, Western; Cell Line; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Iodides; Ion Channel Gating; Models, Molecular; Mutant Proteins; Protein Structure, Secondary; Protein Structure, Tertiary; Protein Transport; Quinolizines; Structure-Activity Relationship | 2010 |
Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.
Topics: 1-Deoxynojirimycin; Aminopyridines; Benzamides; Benzodioxoles; Cell Survival; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; HeLa Cells; Humans; Thiazoles | 2014 |